Healthcare Pharmaceutical Investment Opportunity
Tags : Australia, Australia China, Australian innovation, biopharmaceutical, business, CHAFTA, China, China (ChAFTA), Contact Dr Caroline Hong, Dr Caroline Hong, healthare supplement, Healthcare, Heart health, Hon Andrew Stoner, innovation, investment, Muscle, nutraceutical, Pharmaceuticals, Tocotrienols, Tocotrienols (T3), Trade, Vitamins, Well Being, Wellness
Comments : Off
A biopharmaceutical/nutraceutical company developing therapeutic agents based on natural tocotrienols (T3), targeting global unmet market needs. Tocotrienols are members of the vitamin E family, and an essential nutrient for the body.
Market ready, planning commercialisation launch in 2016.
Investment Opportunities exist for strategic partnerships for this company.
Email us:
carolinehong@carolinehong.com.au and carolinehong1@yahoo.com
(Dr Caroline Hong, Healthcare Project Consultant)
office@andrewstoner.net.au (Hon Andrew Stoner, Healthcare Project Consultant)